M. Lazăr

发表

Vaccine effectiveness against influenza A(H3N2) and B among laboratory‐confirmed, hospitalised older adults, Europe, 2017‐18: A season of B lineage mismatched to the trivalent vaccine

M. Valenciano, F. Galtier, A. Meijer, 2020, Influenza and Other Respiratory Viruses.

Epidemiological and molecular investigation of a rubella outbreak, Romania, 2011 to 2012

A. Mankertz, G. Mihăescu, G. Necula, 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15–64-year-olds in Europe: exploration by birth cohort

M. Valenciano, S. Buda, R. Guiomar, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Whole-Genome Sequences of the Severe Acute Respiratory Syndrome Coronavirus-2 obtained from Romanian patients between March and June of 2020

T. Durfee, R. Stan, Barbara Mühlemann, 2020, bioRxiv.

Respiratory Nasal Mucosa in Chronic Rhinosinusitis with Nasal Polyps versus COVID-19: Histopathology, Electron Microscopy Analysis and Assessing of Tissue Interleukin-33

I. I. Jeican, L. Barbu-Tudoran, C. Iuga, 2021, Journal of clinical medicine.

Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania

A. Pistol, A. Stănescu, M. Lazăr, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021

S. de Lusignan, H. D. de Melker, M. Valenciano, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Immunolocalization and Distribution of Rubella Antigen in Fatal Congenital Rubella Syndrome

C. Paddock, S. Zaki, E. Lupulescu, 2015, EBioMedicine.

Evidence of SARS-CoV-2 Virus in the Middle Ear of Deceased COVID-19 Patients

I. I. Jeican, L. Barbu-Tudoran, D. Gheban, 2021, Diagnostics.

Virological surveillance of influenza viruses in the WHO European Region in 2019/20 – impact of the COVID-19 pandemic

J. Mossong, M. Castrucci, R. Pebody, 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Surveillance of medically‐attended influenza in elderly patients from Romania—data from three consecutive influenza seasons (2015/16, 2016/17, and 2017/18)

A. Streinu-Cercel, D. Pițigoi, A. Ivanciuc, 2020, Influenza and other respiratory viruses.

Transmission and molecular characterisation of wild measles virus in Romania, 2008 to 2012.

A. Mankertz, G. Necula, S. Santibanez, 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.

M. Valenciano, C. Rizzo, F. Pozo, 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Ongoing measles outbreak in Romania, 2011.

G. Necula, E. Lupulescu, A. Pistol, 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Spotlight on measles 2010: An ongoing measles outbreak in the district of Neamt, Romania, August - September 2010.

G. Necula, E. Lupulescu, M. Muscat, 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

2015/16 I‐MOVE/I‐MOVE+ multicentre case‐control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage‐mismatched influenza B among children

M. Valenciano, C. Rizzo, R. Guiomar, 2018, Influenza and other respiratory viruses.

Histopathological Lung Findings in COVID-19 B.1.617.2 SARS-CoV-2 Delta Variant

I. I. Jeican, D. Gheban, C. Crivii, 2023, Journal of personalized medicine.

Neurologic Complications of Influenza B Virus Infection in Adults, Romania

S. Ruță, E. Lupulescu, E. Ceaușu, 2017, Emerging infectious diseases.

Fatal Form of COVID-19 in a Young Male Bodybuilder Anabolic Steroid Using: The First Autopsied Case

I. I. Jeican, D. Gheban, C. Toader, 2022, Medicina.

Characteristics of influenza in elderly patients with and without diabetes, hospitalized for severe acute respiratory infection in a tertiary care hospital from Bucharest Romania - a three-year prospective epidemiological surveillance study.

A. Streinu-Cercel, D. Pițigoi, A. Ivanciuc, 2019, GERMS.

Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017–18)

M. Valenciano, S. Buda, C. Rizzo, 2019, Vaccine: X.

Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre study

M. Valenciano, S. Buda, R. Guiomar, 2022, Influenza and other respiratory viruses.

Identification of SARS-CoV-2 and Enteroviruses in Sewage Water—A Pilot Study

M. Lazăr, A. Băicuș, C. Cherciu, 2021, Viruses.

Differentiation of influenza B lineages from clinical samples by one-step real-time RT-PCR.

G. Necula, E. Lupulescu, D. Pițigoi, 2014, Roumanian archives of microbiology and immunology.

Subacute myoclonic measles encephalitis – An opportunistic HIV-associated infection

H. Vinters, R. Ellis, C. Achim, 2023, Frontiers in Cellular Neuroscience.

Mind your Ps: A probabilistic model to aid the interpretation of molecular epidemiology data

David Williams, A. Fernández-García, M. Lazăr, 2022, EBioMedicine.

M. Valenciano, C. Rizzo, F. Pozo, 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021

M. Valenciano, G. Fagherazzi, F. Galtier, 2023, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study

A. Carnahan, V. Enouf, M. Hooiveld, 2024, Influenza and Other Respiratory Viruses.

Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022–23 VEBIS multicentre study in Europe

M. Hooiveld, A. Larrauri, E. Kissling, 2024, Vaccine.

Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024

M. Hooiveld, E. Kissling, B. Oroszi, 2024, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.